Trial
NCT05156905
Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Diego
Collaborators
—
Condition
Metastatic Castration-resistant Prostate Cancer
Intervention
Cirmtuzumab
Why stopped
Oncternal closing clinical trial operations.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-09